Publication | Closed Access

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Primary Peritoneal CarcinomaGynecological SurgeryMedicineRecurrent Epithelial OvarianGynecologyPhase Ii StudyCancer TreatmentOncologyRadiation OncologyGynecology OncologyEndocrine-related CancerOvarian Cancer